Singapore’s healthtech startup Mito Health raised $2.2 M Seed funding

With plans to build an AI preventive health doctor, Singapore-based Mito Health has raised an additional $2.2 million in seed funding, bringing its total funds raised to $4 million.
“We want to extend our gratitude to our new investors — Y Combinator, Capital X, XA Network, Balaji Srinivasan, Nir Eyal (best-selling author of Hooked), Kevin Aluwi (Co-founder of GoJek), Nas Daily, Alex Svanevik (CEO of Nansen), Prashanth Prakash (Partner at Accel), Dhruv Arora (Co-founder of Syfe) alongside many others — and to our existing investor, Forge Ventures,” Co-Founder and Chief Executive Officer Kenneth Lou wrote in a post on its website.
“We are equally excited to welcome renowned longevity researcher Professor Brian Kennedy to our scientific advisory committee. He brings over 40 years of experience studying the biological processes of aging and developing clocks like LinAge, a blood-based formula for assessing biological age,” he added.
Lou claims that since its San Francisco debut last summer, the business has grown to all 50 states and collaborated with labs such as LabCorp and BioReference.
According to him, its extensive blood testing program, which covers more than 100 biomarkers, has assisted clients in identifying illness early on and achieving optimal health.
“We have also partnered with companies like BodySpec (DEXA scans) and Prenuvo (preventative MRIs) to give our customers deeper insights into their health,” he added.
With offices in Singapore, the US, and San Francisco, Mito Health is developing an AI concierge medical service. The business uses blood work to advise clients on how to prolong their lives and prevent illness. Additionally, the business offers them individualized insights and simple, doable actions related to nutrition, exercise, and supplements.